Former Red Sox pitcher and Dana-Farber patient Curt Schilling announced he will return to ESPN as a studio analyst after he took a leave of absence following his cancer diagnosis.
Tags: OralCancer, HeadNeckCancers
Former Dana-Farber/Boston Children’s Cancer and Blood Disorders Center patient Kate Franklin spent the summer interning in the lab of Dr. Loren Walensky, who treated her for leukemia when she was a child.
Steven Chang led a study showing robotic surgery for
prostate cancer may have led to changes in the number of surgeons performing
prostate removals and in the overall cost.
A new program called CaNCURE is a unique partnership between the Initiative
to Eliminate Cancer Disparities at Dana-Farber/Harvard Cancer Center and
Dr. Paul Richardson led a study showing treatment with an investigational oral drug led to stable disease or better response in three fourths of patients with heavily pretreated multiple myeloma.
Dr. Robert Haddad discussed former Red Sox pitcher Curt Schilling’s oral cancer diagnosis
during the WEEI/NESN Jimmy Fund Radio-Telethon.
Dana-Farber has launched an extensive research project into cancer genomics.
John Quackenbush, PhD, commented on a study that showed understanding a tumor's genomic profile is more likely to lead to an effective treatment.
Dr. Koen M. A. Dreijerink participated in a study that suggested the MEN1 mutation is also involved in the formation of breast cancer tumors.
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: